sCD36 has been proposed as a marker of altered tissue CD36 expression122 since its levels correlate with an overexpression of CD36 in tissues and/or cells involved in the physiopathology of the MS, such as adipocytes, myocytes and tissue macrophages88,123,124. The gene discussed is CD36; the disease is myeloid sarcoma.